{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:08:42Z","timestamp":1784758122128,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R44-CA-221487"],"award-info":[{"award-number":["R44-CA-221487"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R41-OD-031942"],"award-info":[{"award-number":["R41-OD-031942"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["USA-WA1\/2020"],"award-info":[{"award-number":["USA-WA1\/2020"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NR-52281"],"award-info":[{"award-number":["NR-52281"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.biopha.2026.119111","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T02:33:47Z","timestamp":1770863627000},"page":"119111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Exosome-mediated antiviral testing system and identification of Punicalagins and Anthocyanidins as promising antiviral agents against SARS-CoV-2"],"prefix":"10.1016","volume":"196","author":[{"given":"Raghuram","family":"Kandimalla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farrukh","family":"Aqil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divyasha","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Wallen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Disha N.","family":"Moholkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeyaprakash","family":"Jeyabalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon D.","family":"Gabbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Severson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7086-0802","authenticated-orcid":false,"given":"Ramesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119111_bib1","unstructured":"WHO, \u3008https:\/\/data.who.int\/dashboards\/covid19\u3009, 2025. (Accessed 01\/09\/2025 2025)."},{"issue":"7843","key":"10.1016\/j.biopha.2026.119111_bib2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/d41586-021-00121-z","article-title":"Fast-spreading COVID variant can elude immune responses","volume":"589","author":"Callaway","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119111_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.575877","article-title":"Naturally occurring bioactives as antivirals: emphasis on coronavirus infection","volume":"12","author":"Ayatollahi","year":"2021","journal-title":"Front Pharm."},{"issue":"3900","key":"10.1016\/j.biopha.2026.119111_bib4","first-page":"1","article-title":"Flavonoids as promising antiviral agents against SARS-CoV-2 infection: a mechanistic review","volume":"26","author":"Tabari","year":"2021","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.biopha.2026.119111_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253489","article-title":"Phenolic compounds disrupt spike-mediated receptor-binding and entry of SARS-CoV-2 pseudo-virions","volume":"16","author":"Goc","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biopha.2026.119111_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/v15040989","article-title":"The flavonoid cyanidin shows immunomodulatory and broad-spectrum antiviral properties, including SARS-CoV-2","volume":"15","author":"Vicente","year":"2023","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.biopha.2026.119111_bib7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s42269-022-00786-0","article-title":"Molecular binding studies of anthocyanins with multiple antiviral activities against SARS-CoV-2","volume":"46","author":"Akinnusi","year":"2022","journal-title":"Bull. Natl. Res Cent."},{"key":"10.1016\/j.biopha.2026.119111_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13851","article-title":"Therapeutic potential of phytoconstituents of edible fruits in combating emerging viral infections","author":"Santhi","year":"2021","journal-title":"J. Food Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119111_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s13071-021-04955-4","article-title":"Virucidal and antiviral activities of pomegranate (Punica granatum) extract against the mosquito-borne Mayaro virus","volume":"14","author":"S","year":"2021","journal-title":"Parasit. Vectors"},{"issue":"2","key":"10.1016\/j.biopha.2026.119111_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.afres.2024.100572","article-title":"Bioactive potential of punicalagin: a comprehensive review","volume":"4","author":"Shabir","year":"2024","journal-title":"Appl. Food Res."},{"key":"10.1016\/j.biopha.2026.119111_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105075","article-title":"Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CL(pro)","volume":"190","author":"Du","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.biopha.2026.119111_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2180-13-187","article-title":"Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry","volume":"13","author":"Lin","year":"2013","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.biopha.2026.119111_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.638187","article-title":"Pomegranate peel extract as an inhibitor of SARS-CoV-2 spike binding to human ACE2 receptor (in vitro): a promising source of novel antiviral drugs","volume":"9","author":"Tito","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.biopha.2026.119111_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.omtn.2022.08.011","article-title":"A model system for antiviral siRNA therapeutics using exosome-based delivery","volume":"29","author":"Wallen","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biopha.2026.119111_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.canlet.2021.02.011","article-title":"Exosome-mediated delivery of RNA and DNA for gene therapy","volume":"505","author":"Munagala","year":"2021","journal-title":"Cancer Lett."},{"issue":"6_Supplement","key":"10.1016\/j.biopha.2026.119111_bib16","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2024-7247","article-title":"Abstract 7247: exosome-mediated delivery of RNA and DNA: enhanced efficiency with polycationic PEI-PEG","volume":"84","author":"Moholkar","year":"2024","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119111_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2015.10.020","article-title":"Bovine milk-derived exosomes for drug delivery","volume":"371","author":"Munagala","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119111_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104330","article-title":"Mahanine, A dietary phytochemical, represses mammary tumor burden in rat and inhibits subtype regardless breast cancer progression through suppressing self-renewal of breast cancer stem cells","volume":"146","author":"Das","year":"2019","journal-title":"Pharm. Res"},{"issue":"2","key":"10.1016\/j.biopha.2026.119111_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5501\/wjv.v5.i2.85","article-title":"Determination of 50% endpoint titer using a simple formula","volume":"5","author":"Ramakrishnan","year":"2016","journal-title":"World J. Virol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119111_bib20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41541-023-00773-0","article-title":"Outlook of pandemic preparedness in a post-COVID-19 world","volume":"8","author":"Williams","year":"2023","journal-title":"npj Vaccin."},{"issue":"5","key":"10.1016\/j.biopha.2026.119111_bib21","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.cell.2020.08.021","article-title":"Emerging pandemic diseases: how we got to COVID-19","volume":"182","author":"Morens","year":"2020","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.biopha.2026.119111_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071832","article-title":"Exosomes as an emerging plasmid delivery vehicle for gene therapy","volume":"15","author":"Wallen","year":"2023","journal-title":"Pharmaceutics"},{"issue":"15","key":"10.1016\/j.biopha.2026.119111_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153700","article-title":"Targeted oral delivery of paclitaxel using colostrum-derived exosomes","volume":"13","author":"Kandimalla","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.biopha.2026.119111_bib24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","article-title":"SARS-CoV-2 pathogenesis","volume":"20","author":"Lamers","year":"2022","journal-title":"Nat. Rev. Microbiol"},{"issue":"5","key":"10.1016\/j.biopha.2026.119111_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bsheal.2021.07.003","article-title":"SARS-CoV-2 spike protein and RNA dependent RNA polymerase as targets for drug and vaccine development: a review","volume":"3","author":"Muhammed","year":"2021","journal-title":"Biosaf. Health"},{"key":"10.1016\/j.biopha.2026.119111_bib26","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.omtn.2022.08.011","article-title":"A model system for antiviral siRNA therapeutics using exosome-based delivery","volume":"29","author":"Wallen","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"7807","key":"10.1016\/j.biopha.2026.119111_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119111_bib28","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.84899","article-title":"The natural tannins oligomeric proanthocyanidins and punicalagin are potent inhibitors of infection by SARS-CoV-2","volume":"12","author":"Chen","year":"2023","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.biopha.2026.119111_bib29","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/s41467-021-21953-3","article-title":"The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA","volume":"12","author":"Cubuk","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119111_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117477","article-title":"Anti-HCV, nucleotide inhibitors, repurposing against COVID-19","volume":"248","author":"Elfiky","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2026.119111_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105145","article-title":"Pomegranate peel extract polyphenols attenuate the SARS-CoV-2 S-glycoprotein binding ability to ACE2 Receptor: in silico and in vitro studies","volume":"114","author":"Suru\u010di\u0107","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"29","key":"10.1016\/j.biopha.2026.119111_bib32","doi-asserted-by":"crossref","first-page":"18280","DOI":"10.1021\/acs.jafc.5c02320","article-title":"Identification of punicalagin as a key bioactive compound responsible for the antimicrobial properties of Punica granatum L. peel extract against Staphylococcus aureus","volume":"73","author":"Salim","year":"2025","journal-title":"J. Agric. Food Chem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119111_bib33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1055\/s-1999-13971","article-title":"Antiviral activities of biflavonoids","volume":"65","author":"Lin","year":"1999","journal-title":"Planta Med."},{"issue":"4","key":"10.1016\/j.biopha.2026.119111_bib34","first-page":"496","article-title":"An in vitro antiviral evaluation of punicalagin toward influenza A virus","volume":"14","author":"Javadi-Farsani","year":"2024","journal-title":"Avicenna J. Phytomed."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:45:55Z","timestamp":1781880355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226001435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":34,"alternative-id":["S0753332226001435"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119111","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosome-mediated antiviral testing system and identification of Punicalagins and Anthocyanidins as promising antiviral agents against SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119111"}}